|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 血管性认知损害诊断的进一步规范化:血管性认知损害分类共识研究组指南显示文摘引言血管性认知损害(vascular cognitive impairment,VCI)诊断共识的缺乏(体现为多种不同评估方案的使用),妨碍了对其理解和治疗的推进.多个国家的大量临床医生和研究人员参与了2个阶段血管性认知损害分类共识研究(Vascular Impairment of Cognition Classification Consensus Study,VICCCS),旨在就VCI的诊断原则(VICCCS-1)和诊断方案(VICCCS-2)达成一致意见.本文提供了VICCCS-2的相关内容.方法使用VICCCS-1达成的原则和已发表的诊断指南作为在线德尔菲(Delphi)调查的参考基点,以期对VCI的临床诊断达成共识.结果共进行了6轮调查,每轮有65~79名专家参与,他们就VICCCS修订的轻度和重度VCI的诊断指南达成共识,并肯定了美国国立神经疾病与卒中研究所-加拿大卒中网(National Institute of Neurological Disorders and Stroke–Canadian Stroke Network,NINDS-CSN)发布的神经心理学评估方案和对影像学检查的推荐意见.讨论VICCCS-2建议规范化应用NINDS-CSN推荐的神经心理学和影像学评估方案诊断VCI,以促进研究协作. | Olivia A. Skrobot Sandra E. Black Christopher Chen Charles DeCarli Timo Erkinjuntti Gary A. Ford Rajesh N. Kalaria John O'Brien Leonardo Pantoni Florence Pasquier Gustavo C. Roman Anders Wallin Perminder Sachdev Ingmar Skoog the VICCCS group Yoav Ben-Shlomo Anthony P. Passmore Seth Love Patrick G. Kehoe 朱婷珂 徐俊 | 2018 | 国际脑血管病杂志2018，26，4： | 58 |
| 2 | A framework infrageneric classification of Carex (Cyperaceae) and its organizing principles显示文摘Phylogenetic studies of Carex L.(Cyperaceae)have consistently demonstrated that most subgenera and sections are para-or polyphyletic.Yet,taxonomists continue to use subgenera and sections in Carex classification.Why?The Global Carex Group(GCG)here takes the position that the historical and continued use of subgenera and sections serves to(i)organize our understanding of lineages in Carex,(ii)create an identification mechanism to break the~2000 species of Carex into manageable groups and stimulate its study,and(iii)provide a framework to recognize morphologically diagnosable lineages within Carex.Unfortunately,the current understanding of phylogenetic relationships in Carex is not yet sufficient for a global reclassification of the genus within a Linnean infrageneric(sectional)framework.Rather than leaving Carex classification in its current state,which is misleading and confusing,we here take the intermediate steps of implementing the recently revised subgeneric classification and using a combination of informally named clades and formally named sections to reflect the current state of our knowledge.This hybrid classification framework is presented in an order corresponding to a linear arrangement of the clades on a ladderized phylogeny,largely based on the recent phylogenies published by the GCG.It organizes Carex into six subgenera,which are,in turn,subdivided into 62 formally named Linnean sections plus 49 informal groups.This framework will serve as a roadmap for research on Carex phylogeny,enabling further development of a complete reclassification by presenting relevant morphological and geographical information on clades where possible and standardizing the use of formal sectional names. | Eric H.Roalson Pedro Jiménez-Mejías Andrew L.Hipp Carmen Benítez-Benítez Leo P.Bruederle Kyong-Sook Chung Marcial Escudero Bruce A.Ford Kerry Ford Sebastian Gebauer Berit Gehrke Marlene Hahn Muhammad Qasim Hayat Mathias H.Hoffmann Xiao-Feng Jin Sangtae Kim Isabel Larridon Étienne Léveillé-Bourret Yi-Fei Lu Modesto Luceño Enrique Maguilla Jose IgnacioMárquez-Corro Santiago Martín-Bravo Tomomi Masaki Mónica Míguez Robert F.C.Naczi Anton A.Reznicek Daniel Spalink Julian R.Starr Uzma Tamara Villaverde Marcia J.Waterway Karen L.Wilson and Shu-Ren Zhang | 2021 | Journal of Systematics and Evolution2021，59，4： | 3 |
| 3 | A framework for mapping industrial emergence显示文摘 | R. Phaal E. O’Sullivan M. Routley S. Ford D. Probert | 2010 | Technological Forecasting & Social Change2010，，2： | 2 |
| 4 | Do statins reduce hepatitis C RNA titers during routine clinical use?显示文摘AIM: To compare hepatitis C virus (HCV) titers in patients with chronic hepatitis C with and without exposure to 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins).METHODS: Medical records were reviewed for 6463 patients with documented HCV infection at a single center between March 2004 and September 2006. Patients with confi rmed viremia and meeting inclusion criteria were assigned to one of three groups: Group A (n = 50), dyslipidemic patients with statin usage during HCV RNA polymerase chain reaction (PCR) determination; Group B (n = 49), dyslipidemic patients with prior or future statin usage but not at the time of HCV RNA PCR determination; and Group C (n = 102), patients without statin usage during the study period. The primary analysis explored the effect of statin therapy on HCV viremia. Secondary analyses assessed class effect, dose response, and effect of other lipid-lowering therapies on HCV viral titers.RESULTS: Median HCV RNA titers did not signif icantly differ among the three groups (Group A: 4 550 000 IU/mL, Group B: 2 850 000 IU/mL, Group C: 3 055 000 IU/mL).For those subjects with longitudinal assessment of HCV viremia prior to and while on statins, there were no signif icant differences between pre- and post-HCV viral titers. Additionally, no differences in HCV titers were observed at any dose level of the most prescribed statin, simvastatin. However, hypertriglyceridemia independently correlated with HCV titers, and niacin exposure was associated with signif icantly lower viral titers (P < 0.05).CONCLUSION: There was no apparent effect of statins on HCV viral replication in this analysis. Further investigation is warranted to explore the possible antiviral properties of triglyceride-lowering agents and their potential role as adjuncts to standard HCV therapy. | Kimberly A Forde Connie Law Rose O’Flynn David E Kaplan | 2009 | World Journal of Gastroenterology2009，15，40： | 2 |
| 5 | The role of the surgeon in the evolution of flexible endoscopy显示文摘 | Morgenthal C B Richards W O Dunkin B J Forde K A Vitale G Lin E | 2007 | Surg Endosc2007，21，6： | 1 |
| 6 | Increased milk production versus reproductive and energy status of high producing dairy cows显示文摘 | HARRISON R O FORD S P | 1990 | J Dairy Sci1990，73，： | 1 |
| 7 | Gras substances显示文摘 | Bernard L O Ford R A | 1998 | Food Technology1998，52，9： | 1 |
| 8 | Object - oriented finite element analysis 显示文摘 | FORD B W R FOSCHI R O STIENER S F | 1990 | Computers and Structures1990，35，： | 1 |
| 9 | Tris(hydroxymethyl) phosphine-capped gold particles templated by DNA as nanowire precursors显示文摘 | HARNACK O FORD W E YASUDA A WESSELS J M | 2002 | Nano Letters2002，2，： | 1 |
| 10 | Sleep-disordered breathing following acutestroke显示文摘 | Harbison J Ford G James O | 2002 | Qjm2002，95，11： | 1 |
| 11 | Performance indices in descriptive sensory analysis-A complimentary screening tool for assessor and panel performance显示文摘 | Tomic O Forde C Delahunty C | 2013 | Food Quality and Preference2013，28，1： | 1 |
| 12 | Object oriented finite element analysis显示文摘 | FORDE B W R FOSCHI R O STIEMER S F | 1990 | Computers&Structures1990，34，3： | 1 |
| 13 | A framework for mapping industrial emergence显示文摘 | R. Phaal E. O’Sullivan M. Routley S. Ford D. Probert | 2010 | Technological Forecasting & Social Change2010，，2： | 1 |
| 14 | Objeet-oriented finite element analysis显示文摘 | FORDE B W R FOSCHI R O STIEMER S F | 1990 | Computers & Structures1990，34，3： | 1 |
| 15 | Progesterone for Premenstrual Syn- drome 显示文摘 | Ford O Lethaby A Mol B | 2006 | Cochrane Database Syst Rev2006，18，4： | 1 |
| 16 | High resolution of human evolutionary trees with polymorphic microsatellites显示文摘 | Bowcok A M Weber J S Ford O R | 1994 | Nature1994，368，： | 1 |
| 17 | Progesterone for premenstrual syndrome显示文摘 | Ford O Lethaby A Mol B | 2008 | The Cochrane Library2008，2，： | 1 |
| 18 | Elevated ala- nine aminotransferase predicts new - onset type 2 diabetes inde- pendently of classical risk factors, metabolic syndrome, and C - reactive protein in the west of Scotland coronary prevention study 显示文摘 | SATTAR N SCHERBAKOVA O FORD I | 2004 | Diabetes2004，53，11： | 1 |
| 19 | A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomiaed Phase Ⅲ clinical trial:has a more radical approach improved survival显示文摘 | Rock K McArdle O Forde P | 2012 | Br J Radiol2012，85，1017： | 1 |
| 20 | A sec chromasome anomaly in a case of gonadaldys gensis(Turners syndrome)显示文摘 | Ford C E Miller O J | 1959 | Lancet1959，1，71： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员